Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$151.44 - $200.09 $726,912 - $960,432
-4,800 Reduced 32.43%
10,000 $1.97 Million
Q2 2023

Jul 26, 2023

SELL
$160.94 - $186.23 $4,989 - $5,773
-31 Reduced 0.21%
14,800 $2.55 Million
Q1 2023

May 04, 2023

BUY
$145.48 - $175.02 $2.16 Million - $2.6 Million
14,831 New
14,831 $2.47 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Waycross Partners, LLC Portfolio

Follow Waycross Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waycross Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waycross Partners, LLC with notifications on news.